Cannatrek ‘evolution’ key to merger, says LGP managing director by Adam Sheldon February 3, 2026February 5, 2026 Leadership changes at Cannatrek and a renewed focus on financial discipline were key to Little Green […]
Compliance gaps, slow licensing and strict rules put Australia at risk on global stage, expert warns by Adam Sheldon November 26, 2025November 26, 2025
Puro cannabis beats wine to win Marlborough’s top business award by Adam Sheldon November 25, 2025February 21, 2026
Rua launches NZ$2m capital raise in bid to reach ‘self-sustaining position’ by Adam Sheldon November 4, 2025February 21, 2026
Little Green Pharma revenue climbs 10% to $10m in September quarter by Adam Sheldon October 30, 2025November 3, 2025
News in brief: Epsilon receives EU, UK GMP certificates; AGH raises $2.6m via placement; Zelira secures loan notes; Bioxyne’s $5m German order by Steve Jones September 17, 2025February 21, 2026
LGP avoids second strike as shareholders back pay report by Adam Sheldon August 25, 2025August 25, 2025
LGP explores more deals after Health House purchase and ‘applauds’ possible crackdown by regulators by Steve Jones February 12, 2025February 13, 2025
German medical market tipped to top €1 billion in next four years by Martin Lane October 17, 2024February 25, 2025
